Lung disease causes more than 200,000 deaths annually in the United States. Although the lung is generally considered slow to respond to disease and injury, it does undergo regenerative processes, … Continue Reading Researchers develop tissue-engineered model of human lung and trachea.
The mucus barrier protects foreign materials and bacteria from entering and/or infecting lungs. In healthy lungs, inhaled matter is typically trapped in airway mucus and subsequently swept away from the … Continue Reading Researchers successfully bypass the mucus barrier in lungs for the first time.
Idiopathic pulmonary fibrosis (IPF) causes a gradual loss of respiratory capacity and can be lethal within a few years. The cause is unknown, although it can be attributed to a … Continue Reading Researchers identify the causal link between telomere shortening and idiopathic pulmonary fibrosis.
A landmark clinical study from researchers at the Toronto Western Hospital provides convincing evidence that a frequently overlooked therapy for genetically-caused emphysema is effective at slowing the progression of the … Continue Reading Landmark clinical trial validates efficacy of treatment for genetically caused emphysema.
Lung diseases like emphysema and pulmonary fibrosis are common among people with malfunctioning telomeres, the ‘caps’ or ends of chromosomes. Now, researchers from Johns Hopkins University say they have discovered … Continue Reading Premature aging of stem cell telomeres, not inflammation, linked to emphysema.
A team led by UC San Francisco has discovered why mucus in the lungs of people with cystic fibrosis (CF) is thick, sticky and difficult to cough up, leaving these … Continue Reading Researchers identify the mechanism cystic fibrosis uses to thicken mucus in the lungs.